Evidence map›Paper›PMID 38668040›Full record

ReviewCurrent oncology (Toronto, Ont.)2024

Large Language Models in Oncology: Revolution or Cause for Concern?

Aydin Caglayan, Wojciech Slusarczyk, Rukhshana Dina Rabbani, Aruni Ghose, Vasileios Papadopoulos, Stergios Boussios

Abstract readReview
In one paragraph

Review in Current oncology (Toronto, Ont.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aydin CaglayanDepartment of Medical Oncology, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK.
Wojciech SlusarczykKent Medway Medical School, University of Kent, Canterbury CT2 7LX, UK.ORCID 0009-0006-5865-4586
Rukhshana Dina RabbaniDepartment of Medical Oncology, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK.ORCID 0000-0001-6662-9504
Aruni GhoseDepartment of Medical Oncology, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK.ORCID 0000-0001-8332-8033
Vasileios PapadopoulosKent and Canterbury Hospital, Canterbury CT1 3NG, UK.
Stergios BoussiosDepartment of Medical Oncology, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK.ORCID 0000-0002-2512-6131

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The technological capability of artificial intelligence (AI) continues to advance with great strength. Recently, the release of large language models has taken the world by storm with concurrent excitement and concern. As a consequence of their impressive ability and versatility, their provide a potential opportunity for implementation in oncology. Areas of possible application include supporting clinical decision making, education, and contributing to cancer research. Despite the promises that these novel systems can offer, several limitations and barriers challenge their implementation. It is imperative that concerns, such as accountability, data inaccuracy, and data protection, are addressed prior to their integration in oncology. As the progression of artificial intelligence systems continues, new ethical and practical dilemmas will also be approached; thus, the evaluation of these limitations and concerns will be dynamic in nature. This review offers a comprehensive overview of the potential application of large language models in oncology, as well as concerns surrounding their implementation in cancer care.

Indexed as

Artificial IntelligenceMedical OncologyHumansNeoplasmsartificial intelligencedeep learningmachine learningnatural language processingoncology

Identifiers

PMID38668040
PMCPMC11049602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.